These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 7834608)
1. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer. Zhuang Z; Merino MJ; Chuaqui R; Liotta LA; Emmert-Buck MR Cancer Res; 1995 Feb; 55(3):467-71. PubMed ID: 7834608 [TBL] [Abstract][Full Text] [Related]
2. Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast. Chuaqui RF; Zhuang Z; Emmert-Buck MR; Liotta LA; Merino MJ Am J Pathol; 1997 Jan; 150(1):297-303. PubMed ID: 9006344 [TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast. Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258 [TBL] [Abstract][Full Text] [Related]
4. Mutation at chromosome 11q23 in human non-familial breast cancer: a microdissection microsatellite analysis. Koreth J; Bethwaite PB; McGee JO J Pathol; 1995 May; 176(1):11-8. PubMed ID: 7616353 [TBL] [Abstract][Full Text] [Related]
5. Allelic deletions at chromosome 11q22-q23.1 and 11q25-qterm are frequent in sporadic breast but not colorectal cancers. Koreth J; Bakkenist CJ; McGee JO Oncogene; 1997 Jan; 14(4):431-7. PubMed ID: 9053840 [TBL] [Abstract][Full Text] [Related]
6. Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast. Radford DM; Fair K; Thompson AM; Ritter JH; Holt M; Steinbrueck T; Wallace M; Wells SA; Donis-Keller HR Cancer Res; 1993 Jul; 53(13):2947-9. PubMed ID: 8391383 [TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity in ductal carcinoma in situ of the breast. Stratton MR; Collins N; Lakhani SR; Sloane JP J Pathol; 1995 Feb; 175(2):195-201. PubMed ID: 7738715 [TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer. Yaremko ML; Kutza C; Lyzak J; Mick R; Recant WM; Westbrook CA Genes Chromosomes Cancer; 1996 Jul; 16(3):189-95. PubMed ID: 8814452 [TBL] [Abstract][Full Text] [Related]
9. Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region. Chen T; Sahin A; Aldaz CM Cancer Res; 1996 Dec; 56(24):5605-9. PubMed ID: 8971163 [TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction. Nayar R; Zhuang Z; Merino MJ; Silverberg SG Hum Pathol; 1997 Mar; 28(3):277-82. PubMed ID: 9042790 [TBL] [Abstract][Full Text] [Related]
11. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q. Radford DM; Fair KL; Phillips NJ; Ritter JH; Steinbrueck T; Holt MS; Donis-Keller H Cancer Res; 1995 Aug; 55(15):3399-405. PubMed ID: 7614479 [TBL] [Abstract][Full Text] [Related]
12. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands. Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768 [TBL] [Abstract][Full Text] [Related]
13. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium. Moinfar F; Man YG; Bratthauer GL; Ratschek M; Tavassoli FA Cancer; 2000 May; 88(9):2072-81. PubMed ID: 10813719 [TBL] [Abstract][Full Text] [Related]
14. Loss of heterozygosity at 11q22-q23 in breast cancer. Carter SL; Negrini M; Baffa R; Gillum DR; Rosenberg AL; Schwartz GF; Croce CM Cancer Res; 1994 Dec; 54(23):6270-4. PubMed ID: 7954477 [TBL] [Abstract][Full Text] [Related]
15. Allelic loss and the progression of breast cancer. Radford DM; Phillips NJ; Fair KL; Ritter JH; Holt M; Donis-Keller H Cancer Res; 1995 Nov; 55(22):5180-3. PubMed ID: 7585569 [TBL] [Abstract][Full Text] [Related]
16. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185 [TBL] [Abstract][Full Text] [Related]
17. Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer. Srivatsan ES; Chakrabarti R; Zainabadi K; Pack SD; Benyamini P; Mendonca MS; Yang PK; Kang K; Motamedi D; Sawicki MP; Zhuang Z; Jesudasan RA; Bengtsson U; Sun C; Roe BA; Stanbridge EJ; Wilczynski SP; Redpath JL Oncogene; 2002 Aug; 21(36):5631-42. PubMed ID: 12165862 [TBL] [Abstract][Full Text] [Related]
18. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer. Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945 [TBL] [Abstract][Full Text] [Related]
19. A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer. Tangir J; Muto MG; Berkowitz RS; Welch WR; Bell DA; Mok SC Oncogene; 1996 Feb; 12(4):735-40. PubMed ID: 8632895 [TBL] [Abstract][Full Text] [Related]